Objective: Currently, there is still no effective strategy to diminish the infarct size (IS) in
patients with ST-segment elevation myocardial infarction (STEMI). According to a previous …

Background We investigated the effect of nicorandil on infarct size, cardiac function
assessed by cardiac magnetic resonance imaging (CMR) and outcomes in ST-segment …

Introduction: Nicorandil may exert cardioprotective effects in ischemic heart disease.
However, its efficacy in combination with early reperfusion is uncertain. The authors …

Background Nicorandil was reported to improve microvascular dysfunction and reduce
reperfusion injury when administered before primary percutaneous coronary intervention. In …

Background: Nicorandil prior to reperfusion by primary percutaneous coronary intervention
(PCI) in patients with ST-segment elevated myocardial infarction (STEMI) has been …

Objective There is controversy whether nicorandil treatment has cardioprotective effects in
patients with acute myocardial infarction (AMI) following percutaneous coronary intervention …

Background—Intravenous nicorandil, a hybrid compound of ATP-sensitive potassium
channel opener and nitric oxide donor, has been reported to ameliorate early functional and …

Objective: To investigate the effect of intracoronary administration of nicorandil prior to
primary percutaneous coronary intervention (PPCI) on myocardial perfusion and short-term …

Background Intravenous nicorandil infusion with percutaneous coronary intervention (PCI)
has been reported to reduce reperfusion injury events and improve cardiac function in …

Background Using the current meta-analysis as well as systematic review, to determine the
curative effect of Nicorandil in comparison of no Nicorandil after elective percutaneous …